Stevanato Group S.p.A.

NYSE STVN

Stevanato Group S.p.A. EBITDA Margin for the year ending December 31, 2023: 25.09%

Stevanato Group S.p.A. EBITDA Margin is 25.09% for the year ending December 31, 2023, a -3.73% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Stevanato Group S.p.A. EBITDA Margin for the year ending December 31, 2022 was 26.06%, a -3.07% change year over year.
Stevanato Group S.p.A. EBITDA Margin for the year ending December 31, 2021 was 26.89%, a 13.84% change year over year.
Stevanato Group S.p.A. EBITDA Margin for the year ending December 31, 2020 was 23.62%, a 18.96% change year over year.
Stevanato Group S.p.A. EBITDA Margin for the year ending December 31, 2019 was 19.86%.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

NYSE: STVN

Stevanato Group S.p.A.

CEO	Mr. Franco Stevanato
IPO Date	July 16, 2021
Location	Italy
Headquarters	Via Molinella, 17
Employees	5,635
Sector	Healthcare
Industries Medical Instruments 3D Printing Cleaning Supplies Containers & Packaging Glass Hardware & Electronics Plastics Robotics

Description

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

Key trends

Past 5 years